BRC News

An award winning documentary about three families deciding whether to be tested for Huntington's disease is being screened at a festival at UCL this month

The BRC has awarded over half a million pounds to groundbreaking experimental medicine research projects in neuroscience. Image courtesy of Mark Lythgoe & Chloe Hutton, Wellcome Images

The international consortium Collaborative Oncological Gene-environment Study (COGS) has had 13 papers published this month in Nature Genetics, representing a significant advance in our understanding of genetic susceptibility to three hormone-related cancers: breast, ovarian and prostate cancer.

BRC-supported researchers have developed new technology which reveals that blood pressure measured close to the heart is much higher during sleep than previously thought.

The Xtreme Everest 2 expedition, which includes UCL, UCLH and BRC-supported researchers, is being featured at science festivals this summer.

Using MRI and blood tests can be as accurate as a standard autopsy of fetuses and newborn babies, according to a paper published in The Lancet. Image courtesy of Wellcome Images

UCLPartners has been designated an Academic Health Science Network (AHSN).

A large multicentre trial has provided answers to a hotly debated issue concerning the treatment of aggressive diffuse large B Cell Lymphomas (DLBCL).

UCL and the University of Cambridge with their NIHR Biomedical Research Centres have supported a successful bid to work in partnership with industry to develop biomedical discoveries into new products and therapies.

A drug used to treat patients with diabetes could offer fresh hope to those affected by the debilitating symptoms of Parkinson’s disease, according to BRC-supported research.

UCL has been ranked 3rd internationally for academic-industry partnerships in a league table published by the Nature Biotechnology journal this month

An international team, including BRC-supported researchers, has identified tests that could help identify the progress of Huntington’s disease in gene positive individuals.

UCLH Cancer Clinical Trials Unit is one of many groups around the country supporting ‘It’s OK to ask’ – the NIHR campaign to encourage engagement in research.

The BRC supported a successful UCL bid as part of a major push to work in partnership with industry to make sure our biomedical discoveries are developed into products. The award, part of the £50m Higher Education Funding Council for England (HEFCE) Catalyst Fund to increase innovation in higher

We want patients to know it's OK to ask!